Malignant Pharyngeal Neoplasm — Trials

Malignant Pharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,255 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 222
Ph III recruiting: 64
Growth YoY: +6.1%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 30.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 451–493 of 493 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05994170	Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma(CTVp1-NPC)	recruiting	N/A	454	Zhongshan People's Hospital, Guangdong, ChinaOTHER	1	Aug 16, 2023	clinicaltrials
NCT03919552	Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma	recruiting	Phase 3	482	Nanfang Hospital, Southern Medical UniversityOTHER	1